System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Eric Bouffet is an expert in Oncology at Hospital for Sick Children (Canada). As of October 2026, ScienceLeadR ranks Eric Bouffet in the top 1% of experts worldwide for Nervous System Neoplasms, Brain Neoplasms and Glioma. Eric Bouffet has authored 992 publications, the most recent in 2026, and is an investigator in 27 clinical trials, 8 of them ongoing. SLR score: 3,726 (community average: 125). How the SLR is computed.

LeadR Profile

Eric Bouffet Hospital for Sick Children Canada
3 726 ScienceLeadR Reputation 3726

Unlock

Register Login
Network Map

Oncology

Subspecialties: Neurology - Pediatrics - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1990 - 2026
Source: PubMed

Hospital for Sick Children

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 992

Citations

Citations: 42 495 1st author: 69 Last author: 173 Unique author: 12

Main journals

Neuro Oncol 215
Pediatr Blood Cancer 79
J Clin Oncol 72
J Neurooncol 58
Childs Nerv Syst 29

Best Journals

J Clin Oncol 22
Lancet Oncol 18
Nat Med 6

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Conquering Infant and Young Children Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes.
PMID 42877971 — radiotherapy, neoplasms, medulloblastoma, therapeutics, child, infant		Pediatr Blood Cancer20260
Precision medicine for pediatric gliomas.
PMID 42762133 — glioma, neoplasms, precision medicine, therapeutics		Curr Opin Oncol20260
Re: Schreck et al. - Critical considerations for BRAF-altered tumors in children.
PMID 42853093 — brain neoplasms, neoplasms, child		Neuro Oncol20260
Efficacy and safety of trametinib use in pediatric brain tumors in a low- to middle-income country.
PMID 42720781 — brain neoplasms, quality of life, safety, brain, neoplasms, income, neurosurgery, therapeutics, nervous system diseases		Childs Nerv Syst20260
"From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes".
PMID 42719701 — brain neoplasms, brain, neoplasms, income, pathology, precision medicine, diagnosis, therapeutics, neuropathology		Front Oncol20260

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6 Study Chair: 1

By phase:

Phase 2 10
N/A 4
Phase 1 4
Phase 1/Phase 2 4
Phase 3 3
Early Phase 1 2

By status:

Completed 15
Recruiting 7
Active not recruiting 2
Not yet recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 26
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 4
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

8 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27 altered High Grade Gliomas
NCT06838676 — glioma, diffuse intrinsic pontine glioma, adolescent, therapeutics, child		Phase 2Recruiting2025
Visual Telerehabilitation in Children Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
NCT06362434 — brain neoplasms, quality of life, reading, vision, ocular, laboratories, brain, hemianopsia, neoplasms, perception, rehabilitation, telerehabilitation, visual fields, lasers, adolescent, therapeutics, visual perception, vision, low, movement, child		N/ANot yet recruiting2024
Lorlatinib for Newly Diagnosed High Grade Glioma With ROS or ALK Fusion
NCT06333899 — radiotherapy, oncogenes, proto-oncogenes, pilot projects, pilots, glioma, receptor protein-tyrosine kinases, astrocytoma, diffuse intrinsic pontine glioma, lymphoma, drug therapy, maintenance, protein-tyrosine kinases, glioblastoma, tyrosine, therapeutics, anaplastic lymphoma kinase, child, infant, chemotherapy		Early Phase 1Recruiting2025
Study of Olutasidenib and Temozolomide in HGG
NCT06161974 — brain neoplasms, glioma, spinal cord, temozolomide, astrocytoma, diffuse intrinsic pontine glioma, thalamus, brain, neoplasms, maintenance, glioblastoma, therapeutics, oligodendroglioma, spinal cord neoplasms, mutation, spine		Phase 2Recruiting2025
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG H3G34 mutant
NCT05843253 — radiotherapy, brain neoplasms, cells, glioma, temozolomide, astrocytoma, diffuse intrinsic pontine glioma, brain, neoplasms, everolimus, glioblastoma, cell cycle		Phase 2Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS